ID: ALA5274714

Max Phase: Preclinical

Molecular Formula: C16H24N2O4

Molecular Weight: 308.38

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)c(O)c(CN2CCC(N3CCOCC3)CC2)o1

Standard InChI:  InChI=1S/C16H24N2O4/c1-12-10-14(19)16(20)15(22-12)11-17-4-2-13(3-5-17)18-6-8-21-9-7-18/h10,13,20H,2-9,11H2,1H3

Standard InChI Key:  HSWDYVHMDLNJFH-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.38Molecular Weight (Monoisotopic): 308.1736AlogP: 0.95#Rotatable Bonds: 3
Polar Surface Area: 66.15Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.39CX Basic pKa: 7.29CX LogP: 0.22CX LogD: -0.04
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.90Np Likeness Score: -0.57

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source